Steve Jobs' Reported Liver Transplant
Newspaper Reports Steve Jobs Had a Liver Transplant Recently; Doctors Weigh In
Transplant Experts' Views continued...
Cohen says that a liver transplant would usually only be done after other treatments -- including chemotherapy and repeated surgeries -- fail.
Humar says chemotherapy doesn't have good response rates for this type of tumor. "It isn't a good option, but it's an option," Cohen counters. "He's correct, but it's still offered to some patients."
Surgeons can transplant a whole liver from a deceased donor or part of a liver from a living donor. The Wall Street Journal didn't report details about Jobs' liver donor.
Shortage of Liver Donors
There are many more people awaiting liver transplants than there are donated livers. "That's probably the biggest challenge," Cohen says.
The system that determines who gets a liver first prioritizes the sickest patients first.
"Some patients who have very severe illness and are tremendously sick could get transplanted with a few days, for example, whereas other patients who are not as sick and their liver disease hasn't progressed as far may end up waiting several months to sometimes several years," Humar says.
Jobs reportedly underwent his liver transplant in Tennessee. Most patients don't travel for their surgery.
Cohen says the nonprofit United Network for Organ Sharing (UNOS), which administers the U.S. organ procurement and transplantation network, recommends getting on the waiting list at transplant centers in more than one region of the country in order to better the odds of getting a transplant sooner rather than later.
For example, Cohen says the national average wait time for a liver is 11.7 months, compared to 2.7 months where he works.
But Cohen says getting on waiting lists in other parts of the country is financially and physically draining for many patients, because they would have to get a referral and go to those centers for an evaluation.
Life After Liver Transplant
After a liver transplant, patients typically stay in the hospital for a week or two and are back to normal activities within three to four months.
Those patients must take immune-suppressing drugs for the rest of their lives, but that shouldn't limit their lives, say Cohen and Humar.
"After transplant, when they're on immunosuppressive drugs, we aim for people to lead active, normal, healthy lives," Cohen says. "There are thousands of people across the country leading very normal lives that are on some form of immune-suppression medication," Humar says.
Taking immune-suppressing drugs means an increased risk of cancer, so patients are monitored with lab tests and scans.
"The monitoring tends to be more intensive early post-transplant," Humar says. "The first few months, they may be looking at lab tests two to three times a week and maybe scans every three months. Once they get beyond a few years, then the lab testing and the scanning will become less frequent."